← SynDRA
MYCOPHENOLATE MOFETIL
SynDRA canonical compound SYN0007406 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Primary target(s) | HCAR2 | IMPDH1 | IMPDH2 |
| Mechanism of action | dehydrogenase inhibitor | inositol monophosphatase inhibitor |
| Indication | organ rejection |
| Disease area | transplant |
All known targets
- IMPDH2
- IMPDH1
- HCAR2
- PTGER2
Mechanisms of action (all sources)
- IMPDH1 INHIBITOR
- Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor
- IMPDH2 INHIBITOR
- dehydrogenase inhibitor
- inositol monophosphatase inhibitor
- PTGER2 MODULATOR
Drug classes
- Anti-Bacterial Agents
- Anti-Infective Agents
- Antibiotics, Antineoplastic
- Antibiotics, Antitubercular
- Antineoplastic Agents
- Antitubercular Agents
- Enzyme Inhibitors
- Antimetabolite Immunosuppressant
Cross-references
Synonyms
- linfonex
- RS-61443
- myclausen
- mycophenolate mofetil hydrochloride
- myfenax
- mycophenolate mofetil HCl
- Mycophenolic acid 2-(4-morpholinyl)ethyl ester
- Myclausen
- Mycophenylate mofetil
- Myhibbin
- NSC-724229
- NSC-758905
- Arzip
- Cellcept
- Mycophenolate mofetil teva
- Myfenax
- CellCept
- Munoloc
- Mycophenolic acid morpholinoethyl ester
- TM-MMF
- Mycophenolatemofetil
- UNII-9242ECW6R0
- HSDB 7436
- Cellcept (TN)
- 2-Morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate
- CHEBI:8764
- C23H31NO7
- Mycophenolate mofetil (CellCept)
- 9242ECW6R0
- 2-(morpholin-4-yl)ethyl (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4-methylhex-4-enoate
- RS-61443-190
- MMF
- ME-MPA
- MMF CellCept(TM)
- R-99
- Mycophenolate mofetil (JAN/USAN)
- CellCept, RS 61443, TM-MMF, Mycophenolate mofetil
- 2-Morpholinoethyl (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate
Reported adverse events
- Infection
- Asthenia
- Constipation
- Headache
- Hypertension
- Hypotension
- Rash
- Tremor
- Vomiting
- Abdominal pain
- Cough
- Dizziness
Look up MYCOPHENOLATE MOFETIL in the interactive SynDRA portal →